Literature DB >> 20733405

Prevalence of primary resistance at baseline in acutely and recently infected subjects enrolled in AIDS clinical trials group protocol 371.

Carrie Dykes, A Lisa Mukherjee, Ronald J Bosch, Elizabeth Connick, Paul A Volberding, Lisa M Demeter.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 20733405      PMCID： PMC2928582          DOI： 10.1097/QAI.0b013e3181d5a800

Source DB:  PubMed          Journal:  J Acquir Immune Defic Syndr        ISSN： 1525-4135            Impact factor:   3.731


× No keyword cloud information.
  13 in total

1.  Prevalence of HIV-1 resistant strains in recent seroconverters.

Authors:  C Balotta; A Berlusconi; A Pan; M Violin; C Riva; A Gori; S Corvasce; R Mazzucchelli; G Facchi; R Velleca; D Senese; L Dehò; M Galli; S Rusconi; M Moroni
Journal:  J Biol Regul Homeost Agents       Date:  2000 Jan-Mar       Impact factor: 1.711

Review 2.  Rates of transmission of antiretroviral drug resistant strains of HIV-1.

Authors:  Palanee Ammaranond; Philip Cunningham; Robert Oelrichs; Kazuo Suzuki; Claire Harris; Leakhena Leas; Andrew Grulich; David A Cooper; Anthony D Kelleher
Journal:  J Clin Virol       Date:  2003-02       Impact factor: 3.168

3.  Update of the drug resistance mutations in HIV-1: Fall 2005.

Authors:  Victoria A Johnson; Francoise Brun-Vezinet; Bonaventura Clotet; Brian Conway; Daniel R Kuritzkes; Deenan Pillay; Jonathan M Schapiro; Amalio Telenti; Douglas D Richman
Journal:  Top HIV Med       Date:  2005 Oct-Nov

4.  Extensive polymorphisms observed in HIV-1 clade B protease gene using high-density oligonucleotide arrays.

Authors:  M J Kozal; N Shah; N Shen; R Yang; R Fucini; T C Merigan; D D Richman; D Morris; E Hubbell; M Chee; T R Gingeras
Journal:  Nat Med       Date:  1996-07       Impact factor: 53.440

5.  Antiretroviral-drug resistance among patients recently infected with HIV.

Authors:  Susan J Little; Sarah Holte; Jean-Pierre Routy; Eric S Daar; Marty Markowitz; Ann C Collier; Richard A Koup; John W Mellors; Elizabeth Connick; Brian Conway; Michael Kilby; Lei Wang; Jeannette M Whitcomb; Nicholas S Hellmann; Douglas D Richman
Journal:  N Engl J Med       Date:  2002-08-08       Impact factor: 91.245

Review 6.  The impact of the M184V substitution on drug resistance and viral fitness.

Authors:  Mark A Wainberg
Journal:  Expert Rev Anti Infect Ther       Date:  2004-02       Impact factor: 5.091

7.  Simple, short peptide derivatives of a sulfonylindolecarboxamide (L-737,126) active in vitro against HIV-1 wild type and variants carrying non-nucleoside reverse transcriptase inhibitor resistance mutations.

Authors:  Romano Silvestri; Marino Artico; Gabriella De Martino; Giuseppe La Regina; Roberta Loddo; Massimiliano La Colla; Massimo Mura; Paolo La Colla
Journal:  J Med Chem       Date:  2004-07-15       Impact factor: 7.446

8.  Persistence of multidrug-resistant HIV-1 in primary infection leading to superinfection.

Authors:  Bluma Brenner; Jean-Pierre Routy; Yudong Quan; Daniela Moisi; Maureen Oliveira; Dan Turner; Mark A Wainberg
Journal:  AIDS       Date:  2004-08-20       Impact factor: 4.177

9.  Infectivity and replication capacity of drug-resistant human immunodeficiency virus type 1 variants isolated during primary infection.

Authors:  Viviana Simon; Neal Padte; Deya Murray; Jeroen Vanderhoeven; Terri Wrin; Neil Parkin; Michele Di Mascio; Martin Markowitz
Journal:  J Virol       Date:  2003-07       Impact factor: 5.103

Review 10.  Prevalence and determinants of transmitted antiretroviral drug resistance in HIV-1 infection.

Authors:  Clare L Booth; Anna Maria Geretti
Journal:  J Antimicrob Chemother       Date:  2007-04-19       Impact factor: 5.790
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.